The pharmacological inhibition of endogenous GX suppressed lymphoma growth in Epstein-Barr virus-infected humanized mice, whereas treatment with sPLA2-modified EVs reversed this phenotype [81]. This evidence concerns the gene PLA2G2A and lymphoma.